Company intelligence / Profile preview

Becton Dickinson

Franklin Lakes, New Jersey, United Statesbd.com ↗

Ownership: Public · BDX
Employees: ~75000
Development stage: Commercial

Overview

BD has a long history of commercialized medical device innovation. Its platforms are widely adopted globally in clinical laboratories and hospitals. Recent launches include the FACSDiscover A8 Cell Analyzer and HemoSphere Alta platform for advanced patient monitoring[7].

Therapeutic areas: OncologyEndocrinologyCardiovascularInfectious Diseases
Modalities: DeviceBiologicSmall molecule
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborations with healthcare providers worldwidePartnerships with academic institutions for research tools developmentStrategic acquisitions such as C.R. Bard and CareFusion to expand product lines

Beyond the preview

Go deeper on Becton Dickinson.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Becton Dickinson.

Explore the full profile